ストックスクリーナーアプリを入手
206.18
1.37%
2.79
アフターアワーズ：
206.18
前日終値:
$203.39
開ける：
$205.07
24時間の取引高:
1.74M
Relative Volume:
0.80
時価総額：
$58.74B
収益：
$21.84B
当期純損益:
$1.68B
株価収益率:
35.37
EPS:
5.8293
ネットキャッシュフロー:
$2.67B
1週間 パフォーマンス:
-0.60%
1か月 パフォーマンス:
+5.41%
6か月 パフォーマンス:
+17.60%
1年 パフォーマンス:
-14.22%
1日の値動き範囲:
$204.12
$207.54
1週間の範囲:
$203.13
$209.27
52週間の値動き範囲:
$162.29
$251.99
Becton Dickinson Co Stock (BDX) Company Profile
BDX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
206.18 | 57.95B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ISRG
Intuitive Surgical Inc
|
523.69 | 186.98B | 9.61B | 2.77B | 2.27B | 7.555 |
|
ALC
Alcon Inc
|
81.62 | 38.83B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.28 | 36.96B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
43.30 | 36.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-09-25 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2025-05-22 | ダウングレード | Citigroup | Buy → Neutral |
| 2025-05-02 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-02 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2025-05-02 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-05-01 | ダウングレード | BofA Securities | Buy → Neutral |
| 2025-05-01 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2025-05-01 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2024-10-01 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2023-07-24 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-05-05 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2023-04-12 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2023-01-03 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-12-12 | アップグレード | Citigroup | Sell → Neutral |
| 2022-07-11 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-06-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-03-18 | 再開されました | Raymond James | Mkt Perform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2021-12-08 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-08-06 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-12-15 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-07-09 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-06-01 | 再開されました | Goldman | Buy |
| 2020-03-05 | 開始されました | Citigroup | Neutral |
| 2020-02-07 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-02-07 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2020-02-07 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2020-02-06 | ダウングレード | Cowen | Outperform → Market Perform |
| 2020-01-08 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2019-05-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2018-12-07 | 開始されました | Deutsche Bank | Buy |
| 2018-10-16 | 開始されました | Barclays | Equal Weight |
| 2018-06-21 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-04-10 | アップグレード | Citigroup | Neutral → Buy |
| 2018-01-19 | 再開されました | BofA/Merrill | Buy |
| 2018-01-05 | アップグレード | Citigroup | Sell → Neutral |
| 2018-01-05 | 開始されました | KeyBanc Capital Mkts | Overweight |
| 2018-01-03 | 開始されました | Evercore ISI | Outperform |
| 2017-12-29 | 繰り返されました | Deutsche Bank | Buy |
すべてを表示
Becton Dickinson Co (BDX) 最新ニュース
BD and Ypsomed Expand Partnership to Address Rapidly Growing Biologics Market – Company Announcement - Financial Times
BD to Highlight Advanced Biologics and Large-Volume Delivery Solutions at Pharmapack 2026 - BD Newsroom
Becton, Dickinson and Company $BDX Shares Acquired by Massachusetts Financial Services Co. MA - MarketBeat
Insider Selling: Becton, Dickinson and Company (NYSE:BDX) EVP Sells 1,610 Shares of Stock - MarketBeat
Becton Dickinson EVP Garrison sells $334,005 in BDX stock - Investing.com India
Atherectomy Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 - GlobeNewswire Inc.
BD secures FDA 510(k) clearance for EnCor EnCompass system - Yahoo
Lobbying Update: $1,496,000 of BECTON DICKINSON AND COMPANY lobbying was just disclosed - Quiver Quantitative
Becton, Dickinson Wins FDA Clearance For Next-Gen Breast Biopsy Device, Launch Set For 2026 - Benzinga
BD receives FDA clearance for new breast biopsy system By Investing.com - Investing.com India
BD Receives FDA 510(k) Clearance for EnCor EnCompass Breast Biopsy and Tissue Removal System - Finviz
Manning & Napier Advisors LLC Sells 29,843 Shares of Becton, Dickinson and Company $BDX - MarketBeat
BDXBecton Dickinson & Co Latest Stock News & Market Updates - Stock Titan
Becton, Dickinson and Company $BDX Shares Sold by Pacific Capital Partners Ltd - MarketBeat
BD Names Shawn Bevec as Senior Vice President of Investor Relations - Finviz
BD Names Shawn Bevec as Senior Vice President of Investor Relations – Company Announcement - Financial Times
Sumitomo Mitsui Trust Group Inc. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Is Becton Dickinson (BDX) Pricing Reflect Its Recent Multi‑Year Share Price Declines - Yahoo Finance UK
Assessing Becton Dickinson (BDX) Valuation After Recent Share Moves And Business Separation Plans - Yahoo Finance
BD Announces $110M Investment - citybiz
BD (BDX) Invests $110M to Enhance Syringe Production in Nebraska - GuruFocus
S Bank Fund Management Ltd Raises Holdings in Becton, Dickinson and Company $BDX - MarketBeat
BD Announces $110 Million to Support U.S. Pharmaceutical Supply Chain for Biologic Drugs - Finviz
Becton Dickinson’s Strategic Pivot Enters Critical Phase - AD HOC NEWS
Sterilization Services MarketGlobal Forecast 2025-2032: Coverage of B. Braun, Becton Dickinson, Belimed, Cardinal Health, Ecolab, STERIS, and Sotera Health - Yahoo Finance UK
Hardman Johnston Global Advisors LLC Decreases Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Oregon Public Employees Retirement Fund Purchases 8,019 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Robeco Institutional Asset Management B.V. Cuts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Waters and Biosciences & Diagnostic Solutions unit to combine for $17.5B - MSN
Why We're Not Concerned About Becton, Dickinson and Company's (NYSE:BDX) Share Price - 富途牛牛
HB Wealth Management LLC Grows Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Cerity Partners LLC - MarketBeat
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Maintains Target Price $210 - 富途牛牛
Is BD (BDX) Quietly Recasting Its Surgical Innovation Story With Expanded Phasix Mesh Use in Europe? - simplywall.st
Is Becton Dickinson and Company (BOX) stock a top hedge fund pickJuly 2025 Pullbacks & Free Expert Approved Momentum Trade Ideas - ulpravda.ru
What to Expect From Becton, Dickinson and Company's Next Quarterly Earnings Report - Barchart.com
SG Americas Securities LLC Acquires 76,233 Shares of Becton, Dickinson and Company $BDX - MarketBeat
KLP Kapitalforvaltning AS Sells 31,300 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Benjamin Edwards Inc. Increases Stake in Becton, Dickinson and Company $BDX - MarketBeat
Stifel raises Becton Dickinson stock price target to $215 from $210 - Investing.com Nigeria
Becton Dickinson (BDX): Stifel Raises Price Target to $215 | BDX Stock News - GuruFocus
Stifel raises Becton Dickinson stock price target to $215 from $210 By Investing.com - Investing.com South Africa
Stifel Maintains Becton Dickinson & Co(BDX.US) With Buy Rating, Raises Target Price to $215 - 富途牛牛
The Truth About Becton Dickinson and Co (BDX): Quiet Healthcare Giant, Loud Money Moves - AD HOC NEWS
Becton, Dickinson and Company (BDX) Announces Blackout Period fo - GuruFocus
Becton Dickinson announces temporary blackout period for 401(k) plan stock fund - Investing.com Nigeria
Becton Dickinson & CoOn Dec 30, Bd 401(K) Plan to Enter Blackout Period Due to Waters DealSEC Filing - TradingView — Track All Markets
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Mcdaniel Terry & Co. Sells 74,357 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Bought by D.A. Davidson & CO. - MarketBeat
RBC sees durable growth profile at Becton Dickinson (BDX), raises target - MSN
Becton Dickinson Co (BDX) 財務データ
収益
当期純利益
現金流量
EPS
Becton Dickinson Co (BDX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Garrison Michael David | EVP & Pres Med.Essntl&BioPharm |
Jan 15 '26 |
Sale |
207.46 |
1,610 |
334,005 |
12,095 |
3.24%
1.93%
大文字化:
|
ボリューム (24 時間):